vzphotos/iStock Editorial via Getty Images
AbbVie (NYSE:ABBV) is set to report its first-quarter 2025 earnings on Friday, April 25, ahead of the market open. Wall Street analysts are expecting solid, if moderate, year-over-year growth from the pharmaceutical giant.
Wall Street expectations:
- EPS: $2.39 (+3.5% Y/Y)